Plasma proteomic markers predict risk for bowel resection in inflammatory bowel disease: a retrospective cohort study
Plasma proteomic markers demonstrated superior predictive performance over traditional markers in assessing future bowel resection risk in IBD. Incorporating proteomics into clinical practice could enhance risk stratification and inform early interventions to reduce surgical burdens.
Authors
- J H Sun
- C. Xu
- Shutian Zhang (ORCID: https://orcid.org/0000-0003-1779-9069)
- Na Zeng (ORCID: https://orcid.org/0000-0001-9522-918X)
- Minsi Zhou (ORCID: https://orcid.org/0000-0001-8913-4109)
- Haiyun Shi (ORCID: https://orcid.org/0000-0002-9494-5958)
- Xinyi Xu (ORCID: https://orcid.org/0009-0007-9386-9774)
- Xueping Huang (ORCID: https://orcid.org/0000-0003-2725-6674)
- Shengtao Zhu
- Han Lv
- Jiuyue Ma
- Qi Sun
- Fang Xu
- Peng Li
Institutions
- Capital Medical University (CN)
- Peking University (CN)
- National Clinical Research Center for Digestive Diseases (CN)
- Peking University Cancer Hospital (CN)
- Beijing Friendship Hospital (CN)
Publication Details
- Journal
- International Journal of Surgery
- Published
- 2025-12-22
- DOI
- https://doi.org/10.1097/js9.0000000000004636
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00